Katze lab signs contract with Revalesio to study novel approaches to viral diseases
Posted on
September 14, 2011
Revalesio, a pioneering biotechnology company based in Tacoma, recently signed an 18-month contract with the Katze lab at the UW to bring hope to sufferers of influenza, HIV and hepatitis C. Read more...